{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:39:28Z","timestamp":1790390368324,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ijpharm.2018.07.045","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T02:36:36Z","timestamp":1532140596000},"page":"380-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Effective sustained release of 5-FU-loaded PLGA implant for improving therapeutic index of 5-FU in colon tumor"],"prefix":"10.1016","volume":"550","author":[{"given":"Ling","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2018.07.045_b0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.drudis.2013.01.013","article-title":"Injectable implants for the sustained release of protein and peptide drugs","volume":"18","author":"Agarwal","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2018.07.045_b0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canep.2018.01.009","article-title":"The impact of rectal cancer tumor height on recurrence rates and metastatic location: a competing risk analysis of a national database","volume":"53","author":"Augestad","year":"2018","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.2042-7158.1995.tb05760.x","article-title":"Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers","volume":"47","author":"Boisdron-Celle","year":"1995","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijpharm.2016.12.056","article-title":"Hydrophilic drug encapsulation in shell-core microcarriers by two stage polyelectrolyte complexation method","volume":"518","author":"Dalmoro","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1056-8719(98)00027-6","article-title":"Therapeutic applications of implantable drug delivery systems","volume":"40","author":"Dash","year":"1998","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ijpharm.2018.07.045_b0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2011.03.057","article-title":"Novel microbially triggered colon specific delivery system of 5-Fluorouracil: statistical optimization, in vitro, in vivo, cytotoxic and stability assessment","volume":"411","author":"Dev","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijpharm.2005.07.030","article-title":"Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory","volume":"314","author":"Faisant","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0040","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijpharm.2018.07.045_b0045","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/jps.22066","article-title":"In vivo evaluation of 5-fluorouracil-containing self-expandable nitinol stent in rabbits: efficiency in long-term local drug delivery","volume":"99","author":"Guo","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0050","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1002\/jbm.a.34932","article-title":"5-Florouracil-loaded poly(lactic acid)-poly(caprolactone) hybrid scaffold: potential chemotherapeutic implant","volume":"102","author":"Gupta","year":"2014","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"10.1016\/j.ijpharm.2018.07.045_b0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijpharm.2007.07.005","article-title":"Study on colon-specific pectin\/ethylcellulose film-coated 5-fluorouracil pellets in rats","volume":"348","author":"He","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0060","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/jps.20591","article-title":"Development of a respirable, sustained release microcarrier for 5-fluorouracil I: in vitro assessment of liposomes, microspheres, and lipid coated nanoparticles","volume":"95","author":"Hitzman","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0065","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3109\/03639045.2011.559658","article-title":"Study on hydrophilic 5-fluorouracil release from hydrophobic poly(epsilon-caprolactone) cylindrical implants","volume":"37","author":"Hou","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0070","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1016\/j.biomaterials.2007.08.014","article-title":"An in vivo study of the host tissue response to subcutaneous implantation of PLGA- and\/or porcine small intestinal submucosa-based scaffolds","volume":"28","author":"Kim","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2018.07.045_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2014.02.006","article-title":"Evolution of implantable and insertable drug delivery systems","volume":"181","author":"Kleiner","year":"2014","journal-title":"J. Controll. Release"},{"key":"10.1016\/j.ijpharm.2018.07.045_b0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0168-3659(03)00195-0","article-title":"Microsphere design for the colonic delivery of 5-fluorouracil","volume":"90","author":"Lamprecht","year":"2003","journal-title":"J. Controll. Release"},{"key":"10.1016\/j.ijpharm.2018.07.045_b0085","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1021\/mp400536z","article-title":"Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells","volume":"11","author":"Laquintana","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.xphs.2017.10.012","article-title":"Fabrication and use of poly(d, l-lactide-co-glycolide)-based formulations designed for modified release of 5-fluorouracil","volume":"107","author":"Leelakanok","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0095","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.xphs.2017.10.005","article-title":"Antitumor efficacy and toxicity of 5-fluorouracil-loaded poly(lactide co-glycolide) pellets","volume":"107","author":"Leelakanok","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0100","article-title":"Update on hereditary colorectal cancer: improving the clinical utility of multigene panel testing","author":"Lorans","year":"2018","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.ijpharm.2018.07.045_b0105","first-page":"33","article-title":"Toxicity of 5-fluorouracil","volume":"13","author":"Macdonald","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.ijpharm.2018.07.045_b0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jconrel.2013.08.024","article-title":"PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release","volume":"172","author":"Parent","year":"2013","journal-title":"J. Controll. Release"},{"key":"10.1016\/j.ijpharm.2018.07.045_b0115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1200\/JCO.1998.16.1.301","article-title":"Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer","volume":"16","author":"Piedbois","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2017.07.055","article-title":"Development of biomedical 5-fluorouracil nanoplatforms for colon cancer chemotherapy: influence of process and formulation parameters","volume":"530","author":"Pretel","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/jbm.10156","article-title":"Membrane-encased polymer millirods for sustained release of 5-fluorouracil","volume":"61","author":"Qian","year":"2002","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpharm.2017.08.118","article-title":"Modeling of the burst release from PLGA micro- and nanoparticles as function of physicochemical parameters and formulation characteristics","volume":"532","author":"Rodrigues de Azevedo","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0135","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ctrv.2018.01.001","article-title":"The role of chemotherapy in localized and locally advanced rectal cancer: a systematic revision","volume":"63","author":"Rosello","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0140","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ijpharm.2016.09.076","article-title":"Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells","volume":"513","author":"Safwat","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Shive","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1208\/s12248-015-9723-y","article-title":"Scientific and regulatory standards for assessing product performance using the similarity factor, f2","volume":"17","author":"Stevens","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0155","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.addr.2012.02.005","article-title":"Reservoir-based drug delivery systems utilizing microtechnology","volume":"64","author":"Stevenson","year":"2012","journal-title":"Adv. Drug Deli. Rev."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0160","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1016\/S0142-9612(02)00034-0","article-title":"PEG modulated release of etanidazole from implantable PLGA\/PDLA discs","volume":"23","author":"Wang","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2018.07.045_b0165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejps.2014.10.002","article-title":"In vitro dissolution similarity factor (f2) and in vivo bioequivalence criteria, how and when do they match? Using a BCS class II drug as a simulation example","volume":"66","author":"Xie","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijsu.2017.12.030","article-title":"High tie versus low tie of the inferior mesenteric artery in colorectal cancer: a meta-analysis","volume":"52","author":"Yang","year":"2018","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ijpharm.2018.07.045_b0175","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.colsurfb.2017.10.044","article-title":"Modification of porous PLGA microspheres by poly-l-lysine for use as tissue engineering scaffolds","volume":"161","author":"Yuan","year":"2018","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2018.07.045_b0180","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijpharm.2009.03.015","article-title":"A water-in-oil-in-oil-in-water (W\/O\/O\/W) method for producing drug-releasing, double-walled microspheres","volume":"374","author":"Zheng","year":"2009","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318305222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318305222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:38:18Z","timestamp":1759916298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517318305222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0378517318305222"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.07.045","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective sustained release of 5-FU-loaded PLGA implant for improving therapeutic index of 5-FU in colon tumor","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.07.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}